3630 results for «707»

Filter By

3630 results

Outcomes following transcatheter and percutaneous mitral valve repair

21 Nov 2021 – From PCR London Valves 2021

CLASP study, predictability of post-delivery residual mitral regurgitation, MiCLASP PMCF study, off-pump transapical neochord implantation, pronostic impact of nutritional status, and patients with low, intermediate and high frailty are the focus of this session from PCR LV 2021 devoted to percutaneous and transcatheter mitral valve repair.

Outcomes following transcatheter and percutaneous mitral valve repair

Transcatheter mitral, aortic and pulmonary valve implantation

21 Nov 2021 – From PCR London Valves 2021

Watch this series of videos from PCR London Valves 2021 to learn about acute heart failure hospitalizations following TAVI in the U.S., share a peripheral hospital's experiences with structural valve service modernization, enjoy percutaneous transseptal mitral valve implantation in Brazil, and more!

Transcatheter mitral, aortic and pulmonary valve implantation

Miscellaneous - Paravalvular leak closure, PFO closure and LAA occlusion

21 Nov 2021 – From PCR London Valves 2021

Want to know more about the impact of baseline PFO anatomy on residual right to left shunt after transcatheter closure, transcatheter closure of paravalvular leak, or even percutaneous mitral paravalvular leak closure using CT planning? This PCR London Valves 2021 session is for you!

Miscellaneous - Paravalvular leak closure, PFO closure and LAA occlusion

PCR London Valves 2021 Hotlines / Late-Breaking Trials: bRIGHT, EXPAND, CHOICE-MI

21 Nov 2021 – From PCR London Valves

Real-world outcomes for tricuspid edge-to-edge repair, predictors of heart failure hospitalisation and its impact on clinical outcomes, one-year outcomes after TMVI... View part of the Late-Breaking Trials presented during PCR London Valves 2021.

PCR London Valves 2021 Hotlines / Late-Breaking Trials: bRIGHT, EXPAND, CHOICE-MI

Predictability at release means better MR outcomes; PASCAL platform significance in a matched analysis

21 Nov 2021 – From PCR London Valves 2021

Join Peter Lüdike and Philipp Lurz to learn more about about the latest study regarding the predictability of mitral regurgitation reduction using the PASCAL device.

Predictability at release

EAPCI: patient initiatives around the world

22 Nov 2021 – From PCR London Valves 2021

In this session, you can find out more about the EAPCI Valve for Life initiative and what progress has been made in selected countries, as well as other collaborative initiatives across the world.

EAPCI:  patient initiatives around the world

Challenging Left Main Cases

18 May 2021 – From EuroPCR 2021

Watch this session to learn how to treat a challenging LM case in a young patient, to question the need to treat residual LAD disease after PPCI for an inferior STEMI, to find out more about complex left main bifurcation PCI with OCT control, and to...

Challenging Left Main Cases

Complications during PCI, guidewire entrapment and and unexpected Impella complication

16 Dec 2021 – From GulfPCR-GIM 2021

Watch this series of clinical cases- would you have made the same treatment choices to manage these complications?

- Unusual complication during an angiogram
- When wires give you troube
- Routine PCI complications: a CTO technique to the rescue
- Entrapment and fracture of coronary guidewire
- An unexpected Impella...

Complications during

GulfPCR-GIM 2021 Closing Ceremony

16 Dec 2021 – From GulfPCR-GIM 2021

After a retrospective of the best images of the GulfPCR-GIM 2021 Congress, attend the presentation of the best clinical case award to the 2021 winner and listen to the closing highlights that put an end to this edition.

GulfPCR-GIM 2021 Closing

Left main intervention in 2021

16 Dec 2021 – From GulfPCR-GIM 2021

In this session whose aim is to highlight imaging value, watch the case of a 64-year-old man with diabetes, hypertension and severe interstitial lung disease who presented with new onset of shortness of breath and functional class NYHA II-III for 3 days...

Left main intervention 2021

Technical consideration for left main bifurcation in light of evidence

16 Dec 2021 – From GulfPCR-GIM 2021

Watch this session to get proved that provisional side-branch stenting is recommended for the majority of bifurcation lesions, including the LM, that DK-Crush appears to be the best two-stent technique for important SB with complex stenoses, and that imaging and physiology can optimize stenting strategy decision...

Technical consideration

How to use devices efficiently in calcified lesions

15 Dec 2021 – From GulfPCR-GIM 2021

This case-based and practical guidance session will enable you to know how to tailor the available technology for lesions with high calcium content, understand the limitations of each device used for plaque modification, and overcome difficulties with each modality.

How to use devices efficiently

Ultra low contrast PCI in chronic kidney disease: what tools do we have? How to perform? How to achieve optimal outcome? How low can you go?

22 Dec 2021 – From GulfPCR-GIM 2021

Don't miss this session to understand how to perform ultra-low contrast PCI in complex disease and to discover SyncVision co-registration, Dynamic Coronary Roadmap, and the benefits for Azurion to perform ultra-low contrast PCI.

Ultra low contrast PCI

Mastering PCI in patients with complex lesions, ACS and HBR

22 Dec 2021 – From GulfPCR-GIM 2021

Watch this video if you wish to learn how to treat patients with complex anatomy, HBR feature, and presenting with ACS, to discuss the latest evidence about DAPT in HBR patients with acute coronary syndrome, and to ask open questions about DAPT for HBR patients. 

Mastering PCI in patients

Align to a line: improve clinical outcome of current and future patients with the Evolut platform

22 Dec 2021 – From GulfPCR-GIM 2021

Thanks to this session, aimed at revealing the exceptional performance of Evolut PRO+, learn key considerations for patients with longer life expectancy and explore the pathway to a single-digit pacemaker post-TAVI.

Align to a line: improve

Pushing boundaries in tricuspid therapy - The TricValve solution

22 Dec 2021 – From GulfPCR-GIM 2021

In this session, learn about the TricValve system in the treatment of severe TR and right heart disease, obtain insight from the experts with case scenarios, and understand how the TricValve Transcatheter Bicavel system can help patients with severe TR.

Pushing boundaries in

Optimising TAVI results in patients with small aortic annuli

22 Dec 2021 – From GulfPCR-GIM 2021

This session will enable you to discuss the clinical outcomes of TAVI results in patients with small aortic annuli, learn how to best measure and assess gradients when performing TAVI, and review a case of a patient with small annuli treated with TAVI.

Optimising TAVI results

Complete revascularisation: from defining PCI strategy to PCI optimisation

22 Dec 2021 – From GulfPCR-GIM 2021

In this session on percutaneous coronary intervention, learn about available physiology tools for a full coronary assessment, understand how OCT impacts decision-making to strategise and optimise PCI, and learn through case examples how the use of physiology and OCT impacts daily practice.

Complete revascularisation:

Mitral valve disease: state-of-the-art

21 Nov 2021 – From PCR London Valves 2021

Did you ever wonder what an expert surgeon can achieve today in mitral repair? Have you ever wondered when to treat an asymptomatic patient with severe mitral regurgitation? These are some of the questions this session from PCR London Valves 2021 will try to answer.

Mitral valve disease: state-of-the-art

Transcatheter mitral interventions: the future

21 Nov 2021 – From PCR London Valves 2021

What could be the future of transcatheter mitral valve intervention? Will it be repair or replacement? What are the current limitations? Find parts of the answers to these questions, and many others, in this session shot during the PCR LV 2021 Congress.

Transcatheter mitral interventions: the future
Didn’t find what you were looking for?